Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PPI-Clopidogrel Shows Benefit, But Omeprazole Concern Remains - Study

This article was originally published in The Tan Sheet

Executive Summary

An analysis shows a benefit from using proton pump inhibitors with clopidogrel compared with using the antiplatelet drug alone, but reinforces concerns that the PPI omeprazole diminishes the efficacy of the blood thinner

You may also be interested in...



Public Citizen Urges FDA To Add Sweeping Warnings To PPI Labels

Public Citizen petitions FDA to add several warnings to all proton pump inhibitors, including OTCs – which the agency previously determined do not pose the same level of risk as prescription versions.

Public Citizen Urges FDA To Add Sweeping Warnings To PPI Labels

Public Citizen petitions FDA to add several warnings to all proton pump inhibitors, including OTCs – which the agency previously determined do not pose the same level of risk as prescription versions.

Public Citizen Urges FDA To Add Sweeping Warnings To PPI Labels

Public Citizen petitions FDA to add several warnings to all proton pump inhibitors, including OTCs – which the agency previously determined do not pose the same level of risk as prescription versions.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel